Table 15.4a

Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2003

Recipients of Deceased Donor Kidneys

Discharge Regimen Year of Transplant
1999 2000 2001 2002 2003
Total Patients 5,371 5,206 5,675 5,744 5,429
Steroids Withdrawn 213 245 264 445 458
Rate 4.0% 4.7% 4.7% 7.7% 8.4%
CyA Patients 283 179 83 82 86
Steroids Withdrawn 15 20 2 9 6
Rate 5.3% 11.2% 2.4% 11.0% 7.0%
Tac Patients 150 160 224 212 129
Steroids Withdrawn 11 14 29 31 20
Rate 7.3% 8.8% 12.9% 14.6% 15.5%
CyA+MMF Patients 2,678 2,059 1,714 1,534 1,224
Steroids Withdrawn 70 51 37 58 90
Rate 2.6% 2.5% 2.2% 3.8% 7.4%
Tac+MMF Patients 1,374 1,671 2,331 2,864 3,012
Steroids Withdrawn 75 92 111 226 228
Rate 5.5% 5.5% 4.8% 7.9% 7.6%
CyA+Aza Patients 311 205 106 51 28
Steroids Withdrawn 9 3 3 2 1
Rate 2.9% 1.5% 2.8% 3.9% 3.6%
Tac+Aza Patients 67 49 79 56 42
Steroids Withdrawn 5 11 7 11 3
Rate 7.5% 22.4% 8.9% 19.6% 7.1%
Siro+MMF Patients 8 68 189 214 155
Steroids Withdrawn 0 2 8 10 20
Rate 0.0% 2.9% 4.2% 4.7% 12.9%
CyA+Siro Patients 92 269 251 158 147
Steroids Withdrawn 6 7 5 11 7
Rate 6.5% 2.6% 2.0% 7.0% 4.8%
Tac+Siro Patients 9 234 350 232 281
Steroids Withdrawn 0 16 32 32 21
Rate 0.0% 6.8% 9.1% 13.8% 7.5%
Other Regimen Patients 399 312 348 341 325
Steroids Withdrawn 22 29 30 55 62
Rate 5.5% 9.3% 8.6% 16.1% 19.1%


Source: OPTN/SRTR Data as of May 2, 2005.

Includes patients receiving first transplants of any organ with steroid use at transplant discharge, and who have a functioninggraft and maintenance drug use one year after transplantation.

Transplants prior to year 1999 are not reported due to insufficient reporting of immunosuppressive drug use.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;Siro: Sirolimus.